MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >

MDS Professional Report

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.

The explosion of information on MDS forces us to seek novel, alternative ways to distribute it.  Podcasts gives us an easy and popular way to communicate this information in a short time.

Subscribe!

Season 1

Welcome to season 1 of the MDS Professional Report. We look forward to your feedback!

Season 1: Episode 4:

Do Immune Check Inhibitors have a Role in the Treatment of Higher-Risk MDS?

Dr. Howard S. Oster

This podcast will discuss the combination of azacitidine and pembrolizumab in patients with higher-risk MDS, a personalized prediction model based on clinical and genomic data, the classification of therapy-related MDS as well as the importance of platelet counts as a prognostic factor.

Season 1: Episode 3:

Will Venetoclax Become The New Standard?

Dr. Galia Stemer & Dr. Moshe Mittelman

We will discuss the addition of venetoclax to hypomethylating agents in the treatment of advanced myeloid neoplasms, especially higher-risk myelodysplastic syndromes. We will then report a study testing the efficacy and safety of imetelstat, a new telomerase-inhibitor, in the treatment of patients with lower-risk MDS and anemia following ESA failure.

Season 1: Episode 2:

Don’t Withhold Anti-Neoplastic Treatment from your Hematological Patients Infected by COVID

Moshe Mittelman, MD

Our host, Professor Moshe Mittelman from Tel-Aviv Sourasky Medical Center, will review 4 studies discussing if a COVID diagnosis should impact MDS treatments, therapeutic options for anemia and the use of pevonedistat with azacytidine in high-risk MDS.

Season 1: Episode 1:

TP53 Mutations: Were They Born Equal?

Moshe Mittelman, MD

Our host, Professor Moshe Mittelman from Tel-Aviv Sourasky Medical Center, will review four recent studies on TP53 and MDS.

Review answers to commonly asked questions or get answers to your questions from an MDS expert